Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 17/20 | 0.72 |
| ▸ | KDR | P35968 | 1/20 | 0.60 |
| ▸ | NPC1 | O15118 | 2/20 | 0.56 |
| ▸ | RAB9A | P51151 | 2/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.56 |
| ▸ | MITF | O75030 | 1/20 | 0.56 |
| ▸ | XBP1 | P17861 | 1/20 | 0.56 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.56 |
| ▸ | KLF5 | Q13887 | 1/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL846095 | 0.99 | TRPV1 (0.74) | TRPV1KDRNPC1RAB9AKDM4E | |
| SCHEMBL846530 | 0.91 | TRPV1 (0.82) | TRPV1KDRNPC1RAB9AKDM4E | |
| SCHEMBL845804 | 0.90 | TRPV1 (0.83) | TRPV1KDRNPC1RAB9AKDM4E | |
| SCHEMBL846576 | 0.88 | TRPV1 (0.82) | TRPV1KDRNPC1RAB9AKDM4E | |
| SCHEMBL845892 | 0.88 | KDR (0.70) | TRPV1KDRNPC1RAB9AKDM4E | |
| SCHEMBL846675 | 0.88 | TRPV1 (0.59) | TRPV1KDRNPC1RAB9AKDM4E | |
| SCHEMBL846730 | 0.85 | TRPV1 (0.77) | TRPV1KDRNPC1RAB9AKDM4E | |
| SCHEMBL846823 | 0.84 | TRPV1 (1.00) | TRPV1KDRNPC1RAB9AKDM4E | |
| SCHEMBL846097 | 0.84 | TRPV1 (0.81) | TRPV1KDRNPC1RAB9AKDM4E | |
| SCHEMBL846569 | 0.83 | TRPV1 (0.72) | TRPV1KDRNPC1RAB9AKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1603883-B1 | QUINOLINE-DERIVED AMIDE MODULATORS OF VANILLOID VR1 RECEPTOR | JANSSEN PHARMACEUTICA NV (BE) | 2012-03-28 | — | — | EP | disclosed |